Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-22-016963
Filing Date
2022-04-29
Accepted
2022-04-29 16:17:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 ny20004028x1_s3.htm S-3 228527
2 EXHIBIT 5.1 ny20004028x1_ex5-1.htm EX-5.1 10943
3 EXHIBIT 23.1 ny20004028x1_ex23-1.htm EX-23.1 4075
4 FILING FEES TABLE ny20004028x1_ex107.htm EX-FILING FEES 24341
  Complete submission text file 0001140361-22-016963.txt   269185
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264585 | Film No.: 22875716
SIC: 2834 Pharmaceutical Preparations